annual total liabilities:
$152.81M+$83.58M(+120.71%)Summary
- As of today (September 15, 2025), TARS annual total liabilities is $152.81 million, with the most recent change of +$83.58 million (+120.71%) on December 31, 2024.
- During the last 3 years, TARS annual total liabilities has risen by +$140.63 million (+1154.92%).
- TARS annual total liabilities is now at all-time high.
Performance
TARS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$162.38M+$4.09M(+2.58%)Summary
- As of today (September 15, 2025), TARS quarterly total liabilities is $162.38 million, with the most recent change of +$4.09 million (+2.58%) on June 30, 2025.
- Over the past year, TARS quarterly total liabilities has increased by +$37.78 million (+30.32%).
- TARS quarterly total liabilities is now at all-time high.
Performance
TARS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TARS Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +120.7% | +30.3% |
| 3 y3 years | +1154.9% | +418.4% |
| 5 y5 years | +10000.0% | +4093.8% |
TARS Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1154.9% | at high | +418.4% |
| 5 y | 5-year | at high | >+9999.0% | at high | +4093.8% |
| alltime | all time | at high | >+9999.0% | at high | +4093.8% |
TARS Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $162.38M(+2.6%) |
| Mar 2025 | - | $158.29M(+3.6%) |
| Dec 2024 | $152.81M(+120.7%) | $152.81M(+10.1%) |
| Sep 2024 | - | $138.82M(+11.4%) |
| Jun 2024 | - | $124.60M(+68.2%) |
| Mar 2024 | - | $74.07M(+7.0%) |
| Dec 2023 | $69.24M(+98.0%) | $69.24M(+26.6%) |
| Sep 2023 | - | $54.67M(+32.7%) |
| Jun 2023 | - | $41.20M(+9.0%) |
| Mar 2023 | - | $37.81M(+8.1%) |
| Dec 2022 | $34.96M | $34.96M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $33.84M(+8.0%) |
| Jun 2022 | - | $31.32M(-3.0%) |
| Mar 2022 | - | $32.29M(+165.1%) |
| Dec 2021 | $12.18M(+103.2%) | $12.18M(+8.0%) |
| Sep 2021 | - | $11.27M(+2.7%) |
| Jun 2021 | - | $10.98M(+2.4%) |
| Mar 2021 | - | $10.72M(+78.9%) |
| Dec 2020 | $5.99M(+552.0%) | $5.99M(-12.6%) |
| Sep 2020 | - | $6.86M(+77.0%) |
| Jun 2020 | - | $3.87M(-94.0%) |
| Dec 2019 | $919.00K(+413.4%) | $64.32M |
| Dec 2018 | $179.00K | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of TARS is $152.81M
What is the all time high annual total liabilities for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual total liabilities is $152.81M
What is Tarsus Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, TARS annual total liabilities has changed by +$83.58M (+120.71%)
What is Tarsus Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of TARS is $162.38M
What is the all time high quarterly total liabilities for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly total liabilities is $162.38M
What is Tarsus Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, TARS quarterly total liabilities has changed by +$37.78M (+30.32%)